Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
n-3 Polyunsaturated fatty acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Diseases
1 trial -
new extensively hydrolysed formula
United Therapeutics Europe Ltd
Protein Allergy
1 trial -
new infant formula
United Therapeutics Europe Ltd
Functional Constipation
1 trial -
omega-3 polyunsaturated fatty acids
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Interoception
1 trial -
oxytocin and misoprostol
United Therapeutics Europe Ltd
Postpartum Hemorrhage
1 trial -
pancrelipase with bicarbonate
Ultragenyx UK Limited
Cystic Fibrosis
1 trial -
parecoxib
The First People's Hospital of Lianyungang
Anti-Inflammatory Agents, Non-Steroidal
1 trial -
phosphatidylcholine
Ultragenyx UK Limited
Methionine Adenosyltransferase Deficiency
1 trial -
phytic acid
United Therapeutics Europe Ltd
Iron-deficiency
1 trial -
plasmalyte solution
Hospital Authority, Hong Kong
Cardiac Surgery
1 trial -
postbiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ADHD - Attention Deficit Disorder With Hyperactivity
1 trial -
prazosin hydrochloride
United Therapeutics Europe Ltd
Alcohol Use Disorders
1 trial -
preoperative oral carbohydrate drink
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
probiotic cocktail capsules
Hospital Authority, Hong Kong
Vancomycin-Resistant Enterococci
1 trial -
probiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Necrotizing Enterocolitis
1 trial -
prochlorperazine and benadryl IV
United Therapeutics Europe Ltd
Acute Migraine Headache
1 trial -
rice formula
United Therapeutics Europe Ltd
Cow Milk Allergy
1 trial -
saline
United Therapeutics Europe Ltd
Chorioamnionitis
1 trial -
salvianolate injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Angina, Stable
1 trial -
sapropterin dihydrochloride
BioMarin Pharmaceutical Australia Pty Ltd
Autism Spectrum Disorder
1 trial -
sequential combined AVS
Yang Xiaotian
Primary Aldosteronism
1 trial -
simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib
The First People's Hospital of Lianyungang
Gastrointestinal Stromal Tumors
1 trial -
sodium bicarbonate Ringer's solution
The First People's Hospital of Lianyungang
Hepatic Ischemia
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources